Nebratamig
Nebratamig (GNC-035) is an anti-ROR1/anti-CD3/anti-PD-L1/anti-4-1BB tetra-specific antibody with potential immunostimulatory and antineoplastic activities[1].
Product Specifications
CAS Number
2694723-68-5
Product Name Alternative
GNC-035
UNSPSC
12352203
Target
CD3; PD-1/PD-L1; ROR
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Purity
97.34
Smiles
[Nebratamig]
Molecular Weight
(302.32 kDa)
References & Citations
[1]https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nebratamig
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS060491-100ug 100 µg
ALS2CR1 (NIF3L1) (NM_001136039) Human Over-expression Lysate
Sign In for Pricing
View Details 
MBS9911059-01 48 Well
Canine Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1 (LYVE1) ELISA Kit
Sign In for Pricing
View Details MBS9911059-02 96 Well
Canine Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1 (LYVE1) ELISA Kit
Sign In for Pricing
View Details MBS9911059-03 5x 96 Well
Canine Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1 (LYVE1) ELISA Kit
Sign In for Pricing
View Details